JOSE DE SOUZA CALDEIRA FILHO
7 resultados
Resultados de Busca
Agora exibindo 1 - 7 de 7
Artigo IPEN-doc 24182 Soft systems methodology as a systemic approach to nuclear safety management2017 - VIEIRA NETO, ANTONIO S.; GUILHEN, SABINE N.; RUBIN, GERSON A.; CALDEIRA FILHO, JOSE S.; CAMARGO, IARA M.C.Safety approach currently adopted by nuclear installations is built almost exclusively upon analytical methodologies based, mainly, on the belief that the properties of a system, such as its safety, are given by its constituent parts. This approach, however, doesn’t properly address the complex dynamic interactions between technical, human and organizational factors occurring within and outside the organization. After the accident at Fukushima Daiichi nuclear power plant in March 2011, experts of the International Atomic Energy Agency (IAEA) recommended a systemic approach as a complementary perspective to nuclear safety. The aim of this paper is to present an overview of the systems thinking approach and its potential use for structuring sociotechnical problems involved in the safety of nuclear installations, highlighting the methodologies related to the soft systems thinking, in particular the Soft Systems Methodology (SSM). The implementation of a systemic approach may thus result in a more holistic picture of the system by the complex dynamic interactions between technical, human and organizational factors.Artigo IPEN-doc 09953 Development of biomolecules labelled with sup(177)Lu for cancer therapy2006 - ARAUJO, ELAINE B. de; MENGATTI, JAIR; BARBOZA, MARYCEL F. de; COLTURATO, MARIA T.; OSSO JUNIOR, JOAO A.; CALDEIRA FILHO, JOSE de S.; HERRERIAS, ROSANA; MURAMOTO, EMIKOArtigo IPEN-doc 13820 Radiolabeling of substance P with lutetium-177 and biodistribution study in AR42J pancreatic tumor xenografted Nude mice2008 - ARAUJO, ELAINE B.; PUJATTI, PRISCILLA B.; BARRIO, OFELIA; CALDEIRA, JOSE S.; SUZUKI, MIRIAM F.; MENGATTI, JAIRArtigo IPEN-doc 10585 Genotoxic evaluation of [DOTA,Tyrsup(3)]octreotate labeled with sup(131)I and sup(177)Lu in human peripheral lymphocytes in vitro by micronucleus assay2005 - SUZUKI, M.F.; SILVA, M.A.; CALDEIRA FILHO, J.S.C.; COLTURATO, M.T.; ARAUJO, E.B.; BARTOLINI, P.; OKAZAKI, K.The radiolabeled receptor-binding peptides have being used for cancer diagnosis and therapy. The octreotate, a somatostatin analogue peptide, bound to various tumors expressing sst receptors (thyroid, pancreas, prostrate, melanoma and lymphomas). The amount and the type of receptors for somatostatin influence the tissue uptake. The [DOTA, Tyr3 ]octreotate has been used because of its high affinity to somatostatin subtype receptors sstr2 and sstr5. The pharmacokinetic study showed that the blood clearance is rapid and only 9% of the intravenous injected activity remains in human blood after one hour. The aim of this study was to evaluate the cytogenetic effect of radiolabeled [DOTA, Tyr3 ]octreotate in blood cells in vitro, using the cytokinesis-block micronucleus (MN) assay. This technique allows evaluating the mutagenic effects of both endogenous and exogenous agents at chromosome level. Blood samples of healthy donors were collected in heparinized syringes and exposed to different activities of [DOTA, Tyr3 ]octreotate labeled with with 131I (n=3) and 177Lu (n=3), where radioactive concentration ranged from 600 to 5600 kBq/mL, corresponding to an injected activity of 3.1 to 28.9 GBq in a reference man of 70 kg weight. 131I and 177Lu are beta- and gamma-emitters. After one-hour exposition to radiopharmaceuticals at 37o C, the cells were washed with culture medium for removing the non internalised octreotate and cultivated for 72 hours, according to criteria adopted by the IAEA. The results showed a positive correlation between radioactive concentrations (X) and the frequency of binucleated cells with micronuclei (Y) (P<0.05). The model for the best fit of data was the linear one (Y = a + bX). The equation for [131I-DOTA, Tyr3 ]octreotate was Y = (1.634 ± 0.236) + (0.912 ± 0.137) 10-3 X and for [177Lu-DOTA, Tyr3 ]octreotate was Y = (1.715 ± 0.342) + (0.743 ± 0.135) 10-3 X. The non labeled molecule, [DOTA, Tyr3 ]octreotate, has no influence in the induction of cytogenetic damage. The micronucleus assay with rat pancreatic tumor cells (AR42J) that express the sstr2 receptor for somatostatin, submitted to these radiopharmaceuticals, are in course.Artigo IPEN-doc 08719 Implementacao do sistema da qualidade no Laboratorio de Radiotoxicologia do IPEN2002 - GABURO, J.C.; CALDEIRA FILHO, J.S.; TODO, A.S.; SANCHES, M.; CAMPOS, L.L.Artigo IPEN-doc 13234 Comparison of sup(131)I-TYRsup(3)-octreotate and sup(131)I-DOTA-TYRsup(3)Octreotate: the egffect of DOTA on pharmacokinetics and stability2005 - ARAUJO, E.B. de; MURAMOTO, E.; NAGAMATI, L.T.; CALDEIRA FILHO, J.S.; COUTO, R.M.; SILVA, C.P.G.Artigo IPEN-doc 07090 Incertezas associadas a tecnica de fluorimetria para uranio2001 - CALDEIRA FILHO, J.S.; GABURO, J.C.; RODRIGUES JUNIOR, O.; TODO, A.S.